# OnCo record wigen-biomedicine-technology-shanghai (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/wigen-biomedicine-technology-shanghai/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "wigen-biomedicine-technology-shanghai" ;
  schema:name "Wigen Biomedicine Technology (Shanghai)"@en ;
  schema:alternateName "Wigen Biomedicine Technology (Shanghai) Co., Ltd."@en ;
  schema:description "Wigen Biomedicine Technology (Shanghai) is a China-based biotechnology company running 2 late-stage cancer trials of WJB001."@en ;
  schema:url <https://onco.cc/companies/wigen-biomedicine-technology-shanghai/>, <https://www.wigenbio.com> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://www.wigenbio.com>, <https://clinicaltrials.gov/search?lead=Wigen%20Biomedicine%20Technology%20(Shanghai)%20Co.%2C%20Ltd.> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "CN" ;
  onco:technologies <https://onco.cc/technologies/protac-degrader/> ;
  onco:drugs <https://onco.cc/drugs/wjb001/> ;
  onco:terms <https://onco.cc/terms/pivotal-trial/>, <https://onco.cc/terms/clinical-trial/> .